1. Home
  2. NCA vs ENTA Comparison

NCA vs ENTA Comparison

Compare NCA & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Municipal Value Fund

NCA

Nuveen California Municipal Value Fund

HOLD

Current Price

$8.79

Market Cap

300.3M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.51

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCA
ENTA
Founded
1987
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.3M
407.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NCA
ENTA
Price
$8.79
$14.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
59.6K
302.8K
Earning Date
01-01-0001
11-17-2025
Dividend Yield
3.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$0.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.77
$4.09
52 Week High
$9.12
$15.34

Technical Indicators

Market Signals
Indicator
NCA
ENTA
Relative Strength Index (RSI) 29.66 72.93
Support Level $9.06 $11.89
Resistance Level $9.15 $14.52
Average True Range (ATR) 0.11 0.86
MACD -0.04 0.10
Stochastic Oscillator 3.92 95.27

Price Performance

Historical Comparison
NCA
ENTA

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: